1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => OpenAccess
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


  
    






















































































































    Final Cerebral Infarct Volume Is Predictable by MR Imaging at 1 Week | American Journal of Neuroradiology  
    



















    































    
  
  




    
    

  

      


    

      

  
  
  

    

  

    

  

                
    

      

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



    

  


  


  


  
  
  
  
  
  

  	      


    
      

    
  
    
        
    

  

    
                        

  

                
    

      

	  

		
		

			

			  

  
      
  
  

    

  
  
      
Research ArticleBrain

  
      
Open Access

  
      
Final Cerebral Infarct Volume Is Predictable by MR Imaging at 1 Week
  
    	
T. Tourdias, P. Renou, I. Sibon, J. Asselineau, L. Bracoud, M. Dumoulin, F. Rouanet, J.M. Orgogozo and V. Dousset

  
    	
American Journal of Neuroradiology February 2011,  32 (2) 352-358; DOI: https://doi.org/10.3174/ajnr.A2271 

  
  
  



  


  
  



			

		

	
	
 	
	  
  

		
		

			

			  

  
      
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    
References
  1. 1.↵


    1. Phan  TG, 
    2. Donnan  GA, 
    3. Davis  SM, 
    4. et al
    . Proof-of-principle phase II MRI studies in stroke: sample size estimates from dichotomous and continuous data. Stroke 2006;37:2521–25
    Abstract/FREE Full Text
  2. 2.↵


    1. Warach  S, 
    2. Pettigrew  LC, 
    3. Dashe  JF, 
    4. et al
    . Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging: citicoline 010 investigators. Ann Neurol 2000;48:713–22
    CrossRefPubMedWeb of Science
  3. 3.↵


    1. Warach  S, 
    2. Kaufman  D, 
    3. Chiu  D, 
    4. et al
    . Effect of the glycine antagonist gavestinel on cerebral infarcts in acute stroke patients, a randomized placebo-controlled trial: The Gain MRI Substudy. Cerebrovasc Dis 2006;21:106–11. Epub 2005 Dec 9
    PubMed
  4. 4.↵


    1. Smith  JJ, 
    2. Sorensen  AG, 
    3. Thrall  JH
    . Biomarkers in imaging: realizing radiology's future. Radiology 2003;227:633–38
    PubMedWeb of Science
  5. 5.↵


    1. Wintermark  M, 
    2. Albers  GW, 
    3. Alexandrov  AV, 
    4. et al
    . Acute stroke imaging research roadmap. Stroke 2008;39:1621–28
    Abstract/FREE Full Text
  6. 6.↵


    1. Albers  GW, 
    2. Thijs  VN, 
    3. Wechsler  L, 
    4. et al
    . Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (defuse) study. Ann Neurol 2006;60:508–17
    CrossRefPubMedWeb of Science
  7. 7.↵


    1. Davis  SM, 
    2. Donnan  GA, 
    3. Parsons  MW, 
    4. et al
    . Effects of alteplase beyond 3 h after stroke in the echo-planar imaging thrombolytic evaluation trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol 2008;7:299–309
    CrossRefPubMedWeb of Science
  8. 8.↵


    1. Gaudinski  MR, 
    2. Henning  EC, 
    3. Miracle  A, 
    4. et al
    . Establishing final infarct volume: stroke lesion evolution past 30 days is insignificant. Stroke 2008;39:2765–68
    Abstract/FREE Full Text
  9. 9.↵


    1. Lansberg  MG, 
    2. O'Brien  MW, 
    3. Tong  DC, 
    4. et al
    . Evolution of cerebral infarct volume assessed by diffusion-weighted magnetic resonance imaging. Arch Neurol 2001;58:613–17
    CrossRefPubMedWeb of Science
  10. 10.↵


    1. Tourdias  T, 
    2. Dousset  V, 
    3. Sibon  I, 
    4. et al
    . Magnetization transfer imaging shows tissue abnormalities in the reversible penumbra. Stroke 2007;38:3165–71
    Abstract/FREE Full Text
  11. 11.↵


    1. Renou  P, 
    2. Sibon  I, 
    3. Tourdias  T, 
    4. et al
    . Reliability of the ECASS radiological classification of postthrombolysis brain haemorrhage: a comparison of CT and three MRI sequences. Cerebrovasc Dis 2010;29:597–604. Epub 2010 Apr 23
    CrossRefPubMed
  12. 12.↵


    1. Sibon  I, 
    2. Menegon  P, 
    3. Orgogozo  JM, 
    4. et al
    . Inter- and intraobserver reliability of five MRI sequences in the evaluation of the final volume of cerebral infarct. J Magn Reson Imaging 2009;29:1280–84
    CrossRefPubMed
  13. 13.↵


    1. Sobesky  J, 
    2. Zaro Weber  O, 
    3. Lehnhardt  FG, 
    4. et al
    . Which time-to-peak threshold best identifies penumbral flow? A comparison of perfusion-weighted magnetic resonance imaging and positron emission tomography in acute ischemic stroke. Stroke 2004;35:2843–47
    Abstract/FREE Full Text
  14. 14.↵


    1. Neumann-Haefelin  T, 
    2. Wittsack  HJ, 
    3. Wenserski  F, 
    4. et al
    . Diffusion- and perfusion-weighted MRI: the DWI/PWI mismatch region in acute stroke. Stroke 1999;30:1591–97
    Abstract/FREE Full Text
  15. 15.↵


    1. Hosmer  D, 
    2. Lemeshow  S
    . Applied Logistic Regression.2nd ed. New York: John Wiley and Sons; 2000
  16. 16.↵


    1. Kasner  SE
    . Clinical interpretation and use of stroke scales. Lancet Neurol 2006;5:603–12
    CrossRefPubMedWeb of Science
  17. 17.↵


    Tissue plasminogen activator for acute ischemic stroke: The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995;333:1581–87
    CrossRefPubMedWeb of Science
  18. 18.↵


    1. Hacke  W, 
    2. Kaste  M, 
    3. Bluhmki  E, 
    4. et al
    . Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317–29
    CrossRefPubMedWeb of Science
  19. 19.↵


    1. van der Worp  HB, 
    2. Kappelle  LJ, 
    3. Algra  A, 
    4. et al., 
    5. the TESS Investigators; TESS II Investigators
    . The effect of tirilazad mesylate on infarct volume of patients with acute ischemic stroke. Neurology 2002;58:133–35
    Abstract/FREE Full Text
  20. 20.↵


    1. Beaulieu  C, 
    2. de Crespigny  A, 
    3. Tong  DC, 
    4. et al
    . Longitudinal magnetic resonance imaging study of perfusion and diffusion in stroke: evolution of lesion volume and correlation with clinical outcome. Ann Neurol 1999;46:568–78
    CrossRefPubMedWeb of Science
  21. 21.↵


    1. Ebinger  M, 
    2. Christensen  S, 
    3. De Silva  DA, 
    4. et al
    . Expediting MRI-based proof-of-concept stroke trials using an earlier imaging end point. Stroke 2009;40:1353–58
    Abstract/FREE Full Text
  22. 22.↵


    1. Schiemanck  SK, 
    2. Post  MW, 
    3. Kwakkel  G, 
    4. et al
    . Ischemic lesion volume correlates with long-term functional outcome and quality of life of middle cerebral artery stroke survivors. Restor Neurol Neurosci 2005;23:257–63
    PubMedWeb of Science
  23. 23.↵


    1. Saver  JL, 
    2. Johnston  KC, 
    3. Homer  D, 
    4. et al
    . Infarct volume as a surrogate or auxiliary outcome measure in ischemic stroke clinical trials: The RANTTAS Investigators. Stroke 1999;30:293–98
    Abstract/FREE Full Text
  24. 24.↵


    1. Barrett  KM, 
    2. Ding  YH, 
    3. Wagner  DP, 
    4. et al., 
    5. ASAP Investigators
    . Change in diffusion-weighted imaging infarct volume predicts neurologic outcome at 90 days: results of the Acute Stroke Accurate Prediction (ASAP) trial serial imaging substudy. Stroke 2009;40:2422–7. Epub 2009 May 14
    Abstract/FREE Full Text
  25. 25.↵


    1. Thijs  VN, 
    2. Lansberg  MG, 
    3. Beaulieu  C, 
    4. et al
    . Is early ischemic lesion volume on diffusion-weighted imaging an independent predictor of stroke outcome? A multivariable analysis. Stroke 2000;31:2597–602
    Abstract/FREE Full Text
  26. 26.↵


    1. Pillai  JJ
    . Insights into adult postlesional language cortical plasticity provided by cerebral blood oxygen level-dependent functional MR imaging. AJNR Am J Neuroradiol 2010;31:990–96. Epub 2009 Dec 10
    Abstract/FREE Full Text
  27. 27.↵


    1. Cipriano  LE, 
    2. Steinberg  ML, 
    3. Gazelle  GS, 
    4. et al
    . Comparing and predicting the costs and outcomes of patients with major and minor stroke using the Boston Acute Stroke Imaging Scale neuroimaging classification system. AJNR Am J Neuroradiol 2009;30:703–09. Epub 2009 Jan 22
    Abstract/FREE Full Text
  28. 28.↵


    1. Rha  JH, 
    2. Saver  JL
    . The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke 2007;38:967–73
    Abstract/FREE Full Text
  29. 29.↵


    1. Sormani  MP, 
    2. Bruzzi  P, 
    3. Comi  G, 
    4. et al
    . MRI metrics as surrogate markers for clinical relapse rate in relapsing-remitting MS patients. Neurology 2002;58:417–21
    Abstract/FREE Full Text
  30. 30.↵


    1. Orgogozo  JM
    . The concepts of impairment, disability and handicap. Cerebrovasc Dis 1994;4(suppl):2–6
  31. 31.↵


    1. Duncan  PW, 
    2. Jorgensen  HS, 
    3. Wade  DT
    . Outcome measures in acute stroke trials: a systematic review and some recommendations to improve practice. Stroke 2000;31:1429–38
    Abstract/FREE Full Text
  32. 32.↵


    1. Prentice  RL
    . Surrogate endpoints in clinical trials: definition and operational criteria. Stat Med 1989;8:431–40
    CrossRefPubMedWeb of Science
  33. 33.↵


    1. Merino  JG, 
    2. Latour  LL, 
    3. Todd  JW, 
    4. et al
    . Lesion volume change after treatment with tissue plasminogen activator can discriminate clinical responders from nonresponders. Stroke 2007;38:2919–23
    Abstract/FREE Full Text
  34. 34.↵


    1. Rother  J, 
    2. Schellinger  PD, 
    3. Gass  A, 
    4. et al
    . Effect of intravenous thrombolysis on MRI parameters and functional outcome in acute stroke <6 hours. Stroke 2002;33:2438–45
    Abstract/FREE Full Text
  35. 35.↵


    1. Chalela  JA, 
    2. Kang  DW, 
    3. Luby  M, 
    4. et al
    . Early magnetic resonance imaging findings in patients receiving tissue plasminogen activator predict outcome: insights into the pathophysiology of acute stroke in the thrombolysis era. Ann Neurol 2004;55:105–12
    CrossRefPubMedWeb of Science
  36. 36.↵


    1. Barber  PA, 
    2. Parsons  MW, 
    3. Desmond  PM, 
    4. et al
    . The use of PWI and DWI measures in the design of “proof-of-concept” stroke trials. J Neuroimaging 2004;14:123–32
    CrossRefPubMed
  


  
  



  




  


  
  



  
      
  
  

    
  


  
  



  
      
  
  

     Back to top  


  
  



			

		

		
		

			

			  

  
        
In this issue

    
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



  


  
  



  
      
  
  

    

	  
  

		

          

            

  
      
  
  

     Print  


  
  



  
      
  
  

     Download PDF  


  
  



  
      
  
  

    
 Email Article
  


  
  



  
      
  
  

    
 Citation Tools
  


  
  



          

        

        
        

          

            



  
      
  
  

    

  

    

  
      
  
  

    

  
  
  
  
      
Final Cerebral Infarct Volume Is Predictable by MR Imaging at 1 Week
  
    	
T. Tourdias, P. Renou, I. Sibon, J. Asselineau, L. Bracoud, M. Dumoulin, F. Rouanet, J.M. Orgogozo, V. Dousset

  
    	
 American Journal of Neuroradiology Feb 2011, 32 (2) 352-358; DOI: 10.3174/ajnr.A2271 

  
  
  



  


  
  



  
      
  
  

    

  
    
  
  
    
  
  
    
  


  


  
  



  
      
  
  

    
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  


  
  



  



  


  
  



  
      
  
  

    
  


  
  



          

        

	
 	
	
	


  


  
  



  
      
  
  

    
              Purchase  


  
  



  
        
Jump to section

    
  
  

    
  


  
  



  
      
  
  

    

  

    
 Related Articles
  • No related articles found.
 Cited By...
 More in this TOC Section
 Similar Articles

  



  


  
  



			

		

	
	
 	
	
	


    

  



  

                
    

      

  

    

  
      
  
  

    


Advertisement